Found 6 matching trials
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
PHASE2Primary Objective:
To determine the efficacy of SAR441344 as measured by r...
Status
Active Not Recruiting
Location
Center for Neurology and Spine- Site Number : 8400007
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
PHASE3This is a randomized, open-label, parallel, Phase 3 study with 2-arms for t...
Location
North Central Neurology Associates- Site Number : 8401100
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
PHASE3The purpose of each study is to independently measure the annualized relaps...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham- Site Number : 8401135
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus
PHASE2This is a multinational, randomized, placebo-controlled, parallel treatment...
Status
Active Not Recruiting
Location
Accel Research Sites Network - Birmingham- Site Number : 8400003
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
PHASE3The purpose of this randomized, double-blind, placebo-controlled, parallel ...
Status
Active Not Recruiting
Location
Alabama Neurology Associates- Site Number : 8400115
Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)
PHASE2Primary Objective:
To evaluate the therapeutic efficacy of one dose level ...
Location
Omega Research Consultants Debary Site Number : 8400005